Protamine-induced thrombocytopenia?

Blood

Volumn 121, Issue 15, 2013, Pages 2818-2819

  Cuker, Adam ^a   Cines, Douglas B ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 14; HEPARIN; IMMUNOGLOBULIN G ANTIBODY; PROTAMINE; SEROTONIN; THROMBOCYTE FACTOR 4; ANTIBODY;

ANTIGEN BINDING; ARTERIAL THROMBOEMBOLISM; BEAR; BLOOD LEVEL; CARDIOPULMONARY BYPASS; DIABETIC PATIENT; HEPARIN INDUCED THROMBOCYTOPENIA; HOSPITAL DISCHARGE; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; MOLECULAR WEIGHT; NONHUMAN; NOTE; PATHOGENICITY; PRIORITY JOURNAL; SALMON; SEROCONVERSION; SEROTONIN RELEASE; THROMBOCYTE ACTIVATION; THROMBOCYTOPENIA; ANIMAL; BLOOD; FEMALE; IMMUNOLOGY; MALE;

ANIMALS; ANTIBODIES; CARDIOPULMONARY BYPASS; FEMALE; HEPARIN; HUMANS; MALE; PROTAMINES; THROMBOCYTOPENIA;

MLCS; MLOWN;

EID: 84879456741     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-02-480467     Document Type: Note

References (11)

1. Bakchoul T, Zöllner H, Amiral J, et al. Anti-protamine-heparin antibodies: incidence, clinical relevance and pathogenesis. Blood. 2013;121(15):2821-2827.
2. Lee GM, Welsby IJ, Phillips Bute BP, Ortel TL, Arepally GM. High incidence of antibodies to protamine and protamine/heparin complexes in patients undergoing cardiopulmonary bypass. Blood. 2013;121(15):2828-2835.
3. Gluckman TJ, Segal JB, Schulman SP, et al. Effect of anti-platelet factor-4/heparin antibody induction on early saphenous vein graft occlusion after coronary artery bypass surgery. J Thromb Haemost. 2009;7(9):1457-1464.
4. Pouplard C, Leroux D, Rollin J, et al. Incidence of antibodies to protamine/heparin complexes in cardiac surgery patients and impact on platelet activation in vitro and clinical outcome.In: Proceedings from the American Society of Hematology; December 10-13, 2011; San Diego, CA. Abstract 2217.
5. Warkentin TE, Sheppard JA, Moore JC, Cook RJ, Kelton JG. Studies of the immune response in heparin-induced thrombocytopenia. Blood. 2009;113(20):4963- 4969.
6. Pitsilos S, Hunt J, Mohler ER, et al. Platelet factor 4 localization in carotid atherosclerotic plaques: correlation with clinical parameters. Thromb Haemost. 2003;90(6):1112-1120. (Pubitemid 38004432)
7. Krauel K, Pötschke C, Weber C, et al. Platelet factor 4 binds to bacteria, [corrected] inducing antibodies cross-reacting with the major antigen in heparin-induced thrombocytopenia. Blood. 2011;117(4):1370-1378.
8. Warkentin TE, Kelton JG. Temporal aspects of heparin-induced thrombocytopenia. N Engl J Med. 2001;344(17):1286-1292. (Pubitemid 32372963)
9. Arepally GM, Kamei S, Park KS, et al. Characterization of a murine monoclonal antibody that mimics heparin-induced thrombocytopenia antibodies. Blood. 2000;95(5):1533-1540. (Pubitemid 30120810)
10. Sachais BS, Litvinov RI, Yarovoi SV, et al. Dynamic antibody-binding properties in the pathogenesis of HIT. Blood. 2012;120(5):1137-1142.
11. Greinacher A, Gopinadhan M, Günther JU, et al. Close approximation of two platelet factor 4 tetramers by charge neutralization forms the antigens recognized by HIT antibodies. Arterioscler Thromb Vasc Biol. 2006;26(10):2386-2393. (Pubitemid 44465738)